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■ Abstract
Background: Asthma is a chronic infl ammatory disorder of the airways. The persistence of airway infl ammation depends on a decrease in 
apoptosis of T lymphocytes and eosinophils and survival of these activated cells. T lymphocytes  expressing γδ receptors can be identifi ed 
in human lungs and play an important role in immune defence against pathogens and in the regulation of chronic infl ammation. Aging 
is associated with evidence of some immune dysregulation.
Objective: The aim of this study was to analyze the apoptosis receptors of T lymphocytes in long-lasting asthma, to establish their 
correlation with activation markers such as CD25 + and human leukocyte antigen (HLA)-DR +, and to analyze the  γδ  T cell expression in 
this disease.
Methods: A group of 64 individuals (group A) who had had asthma for more than 30 years (mean age [±SD] 72 ± 5 years) and 61 healthy 
individuals acting as controls – group B with 41 individuals (mean age 79 ± 7 years) and group C with 20 individuals (mean age 38 ± 12 
years) were included in the study. All subjects underwent clinical evaluation and spirometric testing. Peripheral blood cells were stained with 
monoclonal antibodies anti-CD3, anti-CD4, anti-CD8, anti-CD25, anti-TCR γδ, anti-HLA-DR and anti-CD95. Statistical comparisons were 
performed between the asthmatics and the elderly control group and between the elderly control group and the adult control group. 
Results: The average percentage of predicted forced expiratory volume in the fi rst second was 73.6 ± 25.3. The mean values of T cell 
receptors for asthma group A vs elderly control group B vs adult control group C respectively, were the following: CD3, 74.9 ± 7 vs 
74.8 ± 8.8 (P = ns) vs 76.7 ± 4.2 (P = ns); CD4, 48.8 ± 8.7 vs 43.5 ± 10.2 (P = ns) vs 44.8 ± 3.8 (P = ns); CD8, 23.3 ± 7.9 vs 25.7 ± 10.2 
(P = ns) vs 25.6 ± 4.5 (P = ns); CD25, 14.3 ±  5.9 vs 22.4 ± 7.8 (P = .0001) vs 5.5 ± 2.4 (P = .0001); TCR γδ,  2.8 ± 2.1 vs 4.1 ± 3.3 
(P<.05) vs 4.6 ± 2.1 (P= ns); HLA-DR, 18.4 ± 9.2 vs 17.8 ± 5.9 (P= ns) vs 15.4 ± 5.1 (P= ns) and CD95, 49.3 ± 13.7 vs 52.6 ± 12.1 
(P = ns) vs 13.8 ± 10.8 (P = .0001).
Conclusions: The immunological and infl ammatory changes related to ageing may cause an increase in CD95 and CD25 T cell expression. 
In asthma, blood cells may express increased activation and apoptosis markers but in elderly patients taking steroids, these receptors remain 
within normal ranges. The number of γδ T cells may be lower in long-lasting asthma, and have a limited modulatory effect on allergic 
infl ammatory reactions. The evaluation of patients with long-lasting asthma should take into account the immunological and infl ammatory 
changes present in the elderly in order to avoid results being misinterpreted.
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■ Resumen
Antecedentes. El asma es una enfermedad infl amatoria crónica de las vías respiratorias. La persistencia de la infl amación de las vías 
respiratorias depende de la reducción en la apoptosis de linfocitos T y eosinófi los y de la supervivencia de estas células activadas. Los 
linfocitos T que expresan receptores γδ pueden detectarse en los pulmones humanos y juegan un importante papel en la defensa 
inmunológica contra patógenos y en la regulación de la infl amación crónica. El envejecimiento está asociado con manifestaciones de 
desregulación inmunológica. 
Objetivo: El propósito del estudio fue analizar los receptores de apoptosis de los linfocitos T en el asma de larga duración para establecer 
su correlación con los marcadores de activación como los CD25+ y HLADR+, así como analizar la expresión de los linfocitos T γδ en esta 
enfermedad.
Métodos: Participaron en el estudio 64 sujetos (grupo A) que habían padecido asma durante más de 30 años (edad media de 72 ± 5 años) 
y un grupo control de 61 sujetos sanos - grupo B con 41sujetos (edad media de 79 ± 7 años) y grupo C con  20 sujetos (edad media de 
38 ± 12 años). Se realizó la evaluación clínica de todos los sujetos, así como pruebas espirométricas. Las células de sangre periférica se  
marcaron con anticuerpos monoclonales anti-CD3, anti-CD4, anti-CD8, anti-CD25, anti-TCR γδ , anti-HLA-DR y anti-CD95. Se llevaron a cabo 
comparaciones estadísticas entre el grupo de asmáticos y el grupo control de más edad, y entre este último y el grupo control adulto. 
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Resultados: El porcentaje medio del volumen espiratorio máximo previsto en el primer segundo fue 73,6 ± 25,3. Los valores medios 
de receptores de linfocitos T (asma (A) frente a grupo control de personas de más edad (B) frente a grupo control adulto (C) fueron los 
siguientes: CD3, 74,9 ± 7 vs 74,8 ± 8,8 (P= ns) vs 76,7 ± 4,2 (P= ns); CD4, 48,8  ± 8,7 vs 43,5 ± 10,2 (P = ns) vs 44,8 ± 3,8 (P = ns); CD8, 
23,3 ± 7,9 vs 25,7 ± 10,2 (P = ns) vs 25,6 ± 4,5 (P = ns); CD25, 14,3 ± 5,9 vs 22,4±7,8 (P = 0,0001) vs 5,5  ± 2,4 (P = 0,0001); TCR γδ:  
2,8 ± 2,1 vs 4,1 ± 3,3 (P <0,05) vs 4,6 ± 2,1 (P = ns); HLA-DR, 18,4 ± 9,2 vs 17,8 ± 5,9 (P = ns) vs 15,4 ± 5,1 (P = ns) y CD95, 49,3 ± 13,7 vs 
52,6  ± 12,1(P = ns) vs 13,8  ± 10,8 (P = 0,0001).
Conclusiones: Los cambios infl amatorios e inmunológicos relacionados con el envejecimiento pueden causar un aumento en la expresión 
de linfocitos T CD25 y CD95. En el asma, las células sanguíneas pueden expresar un aumento de la activación y de los marcadores de 
apoptosis, pero en los pacientes de edad avanzada que toman esteroides, estos receptores se mantienen dentro de los límites de la 
normalidad. El recuento de linfocitos T γδ puede ser inferior en el asma de larga duración y puede tener un limitado efecto modulador 
en las reacciones infl amatorias alérgicas. Para evitar la interpretación errónea de los resultados al evaluar a pacientes con asma de larga 
duración, se deben tener en cuenta los cambios infl amatorios e inmunológicos presentes en las personas de edad avanzada.
Palabras clave: Asma. Personas de edad avanzada. Apoptosis. TCRγδ. CD25.
Introduction
Asthma is a chronic infl ammatory disorder of the airways, 
characterized by widespread but variable bronchial obstruction 
and by hyper-responsiveness to several triggers in which T 
lymphocytes play a central role [1,2]. Asthmatic patients tend 
to develop progressive decline in pulmonary function that is 
correlated with age, sex, disease duration and severity [3]. In 
the airways of asthmatics helper T cells (T
H
), mainly Type 2 
subclasses are activated and release a wide range of cytokines, 
regulating the recruitment of infl ammatory cells, such as 
eosinophils [1]. Limitation to airways fl ow depends partly on 
the effect of the localised infl ammatory process. 
Apoptosis plays a central role in the development, 
homeostasis, and function of the immune system. In normal 
airways, vascular smooth muscle cells and bronchial 
epithelium express Fas, a member of the tumour necrosis 
factor receptor super family (also called Apo-1 or CD95) that 
undergoes apoptosis upon Fas cross-linking with FasL, which 
is a general mechanism for bronchial homeostasis [4]. In 
asthma, stimuli that promote repair mechanisms may act as a 
switch that induces cellular proliferation and inhibits apoptosis. 
A prolonged survival of infl ammatory cells may contribute 
to the respiratory symptoms. The severity of asthma is also 
inversely correlated with the apoptosis of the eosinophils in 
the airways [5].
In asthma, peripheral T lymphocytes are also characterized 
by a higher expression of activation markers, such as the 
interleukin-2 receptor α chain (CD25), and the human 
leukocyte antigen (HLA)-DR that is involved in antigen 
presentation [1,6].
Although most T lymphocytes express T-cell receptors 
(TCRs) composed of α and ß chains, a high percentage of 
T lymphocytes expressing TCRs with γ and δ chains (TCR 
γδ) are localised in the skin, gut, and lung [7]. These γδ T 
lymphocytes, which represent 1% to 10% of circulating 
mature T lymphocytes, play an important role in immune 
defence against pathogens and in the regulation of chronic 
infl ammation [8]. Higher numbers of TCRγδ lymphocytes have 
been observed in the nasal mucosa of humans with allergic 
rhinitis and in the bronchi alveolar lavage fl uid of patients with 
asthma. These cells can produce T
H
2 cytokines under allergenic 
stimulation, which suggests their participation in allergic 
infl ammation [7]. On the other hand, TCRγδ  lymphocytes 
under microbial stimulation can be activated and produce 
large amounts of interferon (IFN)-γ and down regulate the 
infl ammatory response to allergens. 
Studies that evaluate long-lasting asthma can provide 
important information about changes occurring during disease 
evolution. In such studies the inclusion of elderly patients is 
inevitable so the changes in the immune system with aging 
should always be investigated.
In the elderly, the process of apoptosis is important 
because it allows the rapid clearance of intact senescent cells, 
thus providing a limited tissue injury [9]. During the aging 
process, the damage-induced apoptotic pathways can be 
differently modulated and defi cient apoptotic mechanisms can 
contribute to disease [10]. In addition, the absolute number of 
circulating TCRγδ  lymphocytes can be reduced in old people 
and centenarians as a consequence of the age-related decrease 
of total lymphocyte count [11-13].
The aim of the present study was to analyze the 
apoptosis receptor expression on T lymphocytes (CD3+) 
in long-lasting asthma in elderly patients, and to establish 
a correlation with activation marker expression on T 
lymphocytes (CD25+ and HLADR+). We also aimed to 
analyse TCRγδ lymphocytes in view of their ability to 
modulate the infl ammatory process in this chronic disease. 
Comparisons between asthmatics (group A) and healthy 
individuals of the same age (group B) and between healthy 
elderly individuals (group B) and young healthy individuals 
(group C) were also carried out.
Methods
Subjects 
A group of 64 individuals with mild persistent asthma 
(group A), older than 65 years of age (mean age 72 ± 5 years), 
and a control group with 61 individuals were included in the 
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Table 1. Levels of CD3, CD4 and CD8 T Cells in Asthmatics and in the Control Groups
 Population CD3 CD4 CD8
  Mean (±SD) Mean (±SD) Mean (±SD)
Control - adults (group C) 76.7 ± 4.2 44.8 ± 3.8 25.6 ± 4.5
Control - elderly (group B) 74.8 ± 8.8 43.5 ± 10.2 25.7 ± 10.2
Asthmatics (group A) 74.9 ± 7 48.8 ± 8.7 23.3 ± 7.9
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study. The healthy cohort (control group) included two sub 
groups: the fi rst with 41 elderly individuals (group B) (mean 
age 79 ± 7 years) and the second with 20 young adults (mean 
age 37.8 ± 12.2 years) (group C). All the individuals were 
non-smokers and were selected after informed oral consent 
had been obtained.
All the patients (group A) had a history of intermittent 
chest tightness, wheezing or shortness of breath for at least 30 
years prior to study participation consistent with the diagnosis 
of asthma according to Global Initiative for Asthma. All the 
asthmatics controlled their condition by using 250 µg to 500 µg 
of beclomethasone dipropionate daily and short-acting ß
2
-agonists 
as needed. All other anti-asthmatic drugs were withdrawn at least 
4 weeks prior to the study.
None of the individuals (groups A, B and C) had had 
any respiratory infections in the month previous to their 
inclusion in the study. No other clinically relevant diseases 
were reported. 
The following were considered exclusion criteria: cancer, 
autoimmune disease, infection, diabetes, heart failure, renal 
failure, chronic hepatic disease and recent exposure to 
environmental risk factors for pulmonary diseases. 
Diagnostic Tests 
All patients were examined by a physician and underwent 
spirometric testing using the same equipment (Vitalograph 
Compact) at least 6 hours after the last dose of any 
bronchodilator. Predicted values were measured according to 
Knudson et al [14]. Subjects’ spirometric performances were 
assessed by means of a computerized program following the 
American Thoracic Society (ATS) 94 criteria. Approval for 
analysis was determined using the ATS 94 criteria and accuracy 
was achieved if, within the same evaluation, three curves were 
acceptable and reproducible.
Twenty to 25 mL of peripheral blood was withdrawn from 
the vein of the forearm. Peripheral blood cells were stained 
with monoclonal antibodies anti-CD3 phycoerythrin cyanine 
5 (PECy5) (Dako, Denmark), anti-CD4 PECy5 (Dako) anti-
CD8 phycoerythrin (PE) (Immunotech, Marseille, France), 
anti-CD25 fl uorescein isothiocyanate (FITC) (Immunotech), 
anti-TCRγδ phycoerythrin (PE) (Immunotech), anti-HLA-DR 
FITC (Immunotech), anti-CD95 FITC (Immunotech), used 
as manufacturer`s specifi cations. Flow cytometry data were 
collected on a FACS Calibur device (BD Biosciences, San 
Jose, California, USA) and analysed using Paint-a-gate (BD 
Biosciences) software directed at lymphocytes. 
Statistical analysis was performed using SPSS 12.0 
software package. The Kolmogorov–Smirnov test was 
used to check if variables were normally distributed. For 
those with a normal distribution the parametric t test was 
used for two independent samples. Variables that were not 
distributed normally were evaluated using the Mann-Whitney 
nonparametric test. P values less than .05 were considered 
signifi cant. 
Statistical comparisons were made between young and 
elderly control groups (C and B) and between healthy elderly 
persons (group B) and elderly asthmatics (group A).
Results
All patients (group A) were clinically stable and presented 
an average percentage of predicted forced expiratory volume 
in 1 second of 73.6 ± 25.3 mL.
The mean values of CD3, CD4 and CD8 T cells in the blood 
were within normal ranges, although asthmatic patients showed 
a tendency to present an increase in CD4+ T cells (Table 1).
The activation marker CD25 was increased in the elderly 
healthy population (group B) when compared with the adult 
healthy population (group C). Asthmatic patients (group A) 
had a decreased expression of CD25 when compared with 
control elderly subjects (group B) (P = .0001). The rise in CD25 
expression involved T cells (CD3+). The HLADR values were 
similar in the three groups studied although asthmatics presented 
the higher values (Table 2). A statistically signifi cant negative 
correlation between CD25 and HLADR was found within 
asthmatics (Pearson correlation coeffi cient –0.27; P = .031).
The apoptosis marker, CD95 was signifi cantly increased in 
the elderly control group (group B) when compared with the 
adult control group (group C). Asthmatic patients (group A) 
showed slightly lower CD95 values than the elderly control 
group (group B). A statistically signifi cant negative correlation 
between CD95 and CD3+CD25+ was found within asthmatics 
(Pearson correlation –0.26; P= .044) but was absent (P = ns) 
in healthy control individuals. 
The TCRγδ   cells were over 4% both in adults and the elderly 
control groups and were signifi cantly reduced in asthmatics 
(Table 3). A statistically signifi cant negative correlation between 
γδ lymphocytes and CD95 was obtained only within the control 
elderly group (Pearson correlation –0.44; P = .043).
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Table 2. Levels of CD25, CD25/CD3 and HLADR in Asthmatics and in the Control Groups
 Population CD25 CD25
+CD3+ HLADR
  Mean (±SD) Mean (±SD) Mean (±SD)
Control - adults (group C) 5.5 ± 2.4 3.6 ± 1.4 15.4 ± 5.1
Control - elderly (group B) 22.4 ± 7.8* 19.3 ± 7.0* 17.8 ± 5.9
Asthmatics (group A) 14.3 ± 5.9 12.3 ± 6.3 18.4 ± 9.2
Table 3. Levels of CD95 and TCRγδ Expression in Asthmatics and in 
the Control Groups
 Population CD95 γδ 
  Mean (±SD) Mean (±SD) 
Control - adults 
(group C) 13.8 ± 10.8 4.6 ± 2.1 
Control - elderly 
(group B) 52.6 ± 12.1* 4.1 ± 3.3 
Asthmatics 
(group A) 49.3 ±13.7 2.8 ± 2.1† 
* Student t test, P < .001
† Student t test, P < .05
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Discussion 
This study was carried out to evaluate T cell input, mainly 
the TCRγδ lymphocyte subpopulation and the expression 
of CD95 in lymphocytes in long-lasting asthma, given 
the bronchial chronic infl ammation that characterizes this 
disease.
In the elderly there is an underlying chronic infl ammatory 
state with high circulatory levels of pro-infl ammatory cytokines 
and their receptors, so it was decided to include in this study 
a control adult population to obtain information related to 
the aging process. According to some studies, in elderly, the 
pattern of cytokine production is altered with a shift towards 
a T
H
2 response [15,16]. 
In the present study we found a higher number of CD4+ 
cells in the asthmatic patients, and these are often correlated 
with asthma pathogenesis and disease severity [17]. The CD25 
values were signifi cantly higher in the elderly control group 
when compared with the adult cohort. The immune system 
undergoes considerable qualitative and quantitative changes 
during aging including the display of a number of activation 
markers [18,19]. 
In contrast, CD25 expression was signifi cantly reduced 
while HLADR was higher in the asthmatic patients when 
compared with the same age control group. T lymphocytes 
(CD3+CD25+) from these patients failed to show an additional 
rise of this activation marker (when compared with the elderly 
control group) as has been described in younger asthmatic 
patients. A statistically significant negative correlation 
between CD25 and HLADR was established within the 
asthmatics. This could be associated with the T
H
2 cytokine 
profi le environment which is characteristic of asthma and 
aging and can selectively downregulate IL-2 production and 
IL-2R expression [3,20]. 
In this study the elderly population showed a statistically 
signifi cant increase in CD95 expression when compared with the 
young control group. The elevated levels of CD95 and a higher 
sensitivity to apoptosis induction seem to be a general feature of 
all T cells in the elderly. Apoptosis is involved in many changes 
which are characteristics of immunosenescence [21]. Although 
asthmatic patients showed a lower expression of the apoptosis 
marker CD95, no signifi cant differences were observed between 
affected and healthy elderly individuals. The patients studied 
were taking low doses of inhaled steroids and were asymptomatic. 
According to some studies, steroids can induce apoptosis in 
cells of asthmatic subjects and can also reduced Fas (CD95) 
and CD25 expression [1,22]. In addition, the Fas system is less 
active in the T
H
2 environment which is typical of asthma [23-25] 
A statistically signifi cant negative correlation between CD95 and 
CD3+CD25+ was observed within the asthmatics but not in the 
control group. As the asthmatic patients analysed in the present 
study were older than 65 and were asymptomatic, the decrease 
in CD95 observed was not signifi cant. In spite of this, T cells 
expressing activated markers probably have a lower propensity 
to apoptosis in asthma even in the elderly. 
Although most of the cells participating in the immune 
defence are αß types, there is data suggesting that in asthma 
and in rhinitis there is a small subset of pulmonary γδ T cells 
that produce T
H
2-type cytokines and might control the T
H
2-
driven allergic infl ammation [26,27]. These cells have the skill 
of recognizing different allergens from the environment [28]. In 
this study the γδ lymphocytes were signifi cantly reduced in long-
lasting asthma when compared with the elderly control group. 
This T cell subset is also involved in the defence against pathogens 
and can decrease during the ageing process [29]. However, the 
results of γδ lymphocytes in the healthy adults and the healthy 
elderly groups were similar, reinforcing the hypotheses that the 
observed reduction was associated with asthma pathogenesis. 
A statistically significant negative correlation between γδ 
lymphocytes and CD95 was obtained only within the elderly 
control group. In addition CD95γδ percentage values (1.9 ± 1.4), 
in this healthy population are low (unpublished data) confi rming 
the absence of increased expression of Fas (CD95) in this 
lymphocyte subset. Despite basal infl ammatory changes present 
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in elderly, the γδ lymphocytes showed no particular tendency to 
initiate apoptosis [8,30].
Both proinfl ammatory and antiinfl ammatory properties 
have been recognized in TCRγδ lymphocytes [7,31-34]. 
This T cell subset may develop regulatory activity on 
allergic infl ammation and suppressive effects on airways 
hyperactivity [35]. This T cell subset can produce high levels 
of IFN-γ, which reduces IgE production. The reduced number 
of TCRγδ lymphocytes observed in the patients studied, 
who presented moderate persistent asthma for more than 30 
years, suggests a negligible regulatory activity of these cells 
on disease evolution. Many studies have been performed in 
TCRγδ lymphocytes, but some doubts remain about their 
exact mechanism of action. Their role in infl ammation seems 
to depend on the environmental conditions.
In conclusion, in the elderly there is a higher level of 
CD95 and CD25 T cell expression. In elderly asymptomatic 
asthmatics, taking inhaled steroids, these receptors stay within 
normal range values when compared with the same age group, 
but T cells displaying activated markers probably have a lower 
propensity to apoptosis in asthma even in the elderly. γδ T 
cells may be reduced in long-lasting asthma and may play a 
minor role in the infl ammatory changes of this disease. Finally, 
long-lasting asthma evaluation should take into account the 
immunological and infl ammatory changes found in the elderly 
to avoid results being misinterpreted.
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